Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase I trial of zika virus vaccine

Trial Profile

A phase I trial of zika virus vaccine

Planning
Phase of Trial: Phase I

Latest Information Update: 29 Apr 2016

At a glance

  • Drugs Zika virus vaccine (Primary)
  • Indications Zika virus infection
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 29 Apr 2016 New trial record

Trial Overview

Purpose

This trial will investigate zika virus vaccine.

Diseases Treated

Indication Qualifiers Patient Segments
Zika virus infection prevention -

Subjects

  • Subject Type volunteers
  • Sex male & female
  • Age Group adult

Patient Inclusion Criteria

Healthy volunteers

Trial Details

Organisations

  • Affiliations Imutex

Trial Dates

Other Details

  • Design prospective
  • Phase of Trial Phase I
  • Location USA
  • Focus Adverse reactions; First in man

Interventions

Drugs Route Formulation
Zika virus vaccinePrimary Drug
-
-

Zika virus vaccine

Trial Centres

Centres

Centre Name Location Trial Centre Country
National Institute of Health Clinical Center Bethesda, Maryland USA

Trial History

Event Date Event Type Comment
29 Apr 2016 New trial record New trial record Updated 29 Apr 2016

References

  1. hVIVO. hVIVO Announces a Joint Venture Investment with the SEEK Group to Develop Vaccines against Flu and Zika Infections. Media-Rel 2016;.

    Media Release
Back to top